Mauna Kea Technologies SA (MKEA.PA)

0.634 €

-0.01 (-1.25%)
Rating:
Recommendation:
-
Symbol MKEA.PA
Price 0.634 €
Beta 1.859
Volume Avg. 0.38M
Market Cap 28.225M
Shares () -
52 Week Range 0.371-1.142
1y Target Est -
DCF Unlevered MKEA.PA DCF ->
DCF Levered MKEA.PA LDCF ->
ROE -
ROA -
Operating Margin -
Debt / Equity -339.57% Strong Sell
P/E -
P/B -2.57 Strong Sell
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Mr. Robert Gershon
Healthcare
Medical Devices
Paris

Mauna Kea Technologies SA develops and markets medical devices in Europe, the Middle East, Africa, the United States, Latin America, and Asia. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.